Amir H Kashani1, Gilberto R Lopez Jaime, Saloomeh Saati, Gabriel Martin, Rohit Varma, Mark S Humayun. 1. *Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, California; †Reichert Technologies, Buffalo, New York; and Departments of ‡Neuroscience, and §Biomedical Engineering, University of Southern California, Los Angeles, California.
Abstract
PURPOSE: This pilot study was aimed to demonstrate the clinical feasibility of using hyperspectral computed tomographic spectroscopy to measure blood oxygen content in human retinal vessels. METHODS: All procedures were performed under a University of Southern California Institutional Review Board-approved protocol and after obtaining informed consent. Fifty-seven subjects with and without diabetic retinopathy were dilated for standard fundus photography. Fundus photographs and retinal vascular oxygen measurements (oximetry) were made using a custom-made hyperspectral computed tomographic imaging spectrometer coupled to a standard fundus camera. Oximetry measurements were made along arteries (Aox) and veins (Vox) within vessel segments that were 1 to 2 disk diameters from the optic disk. RESULTS: For all control subjects (n = 45), mean Aox and Vox were 93 ± 7% and 65 ± 5% (P = 0.001), respectively. For all diabetic subjects (n = 12), mean Aox and Vox were 90 ± 7% and 68 ± 5% (P = 0.001), respectively. In subjects with proliferative diabetic retinopathy, Aox was significantly lower, and Vox was significantly higher than other groups (85 ± 4% and 71 ± 4%, respectively; P = 0.04, analysis of variance). There was a highly significant difference in the arteriovenous difference between subjects with proliferative diabetic retinopathy and those in the control group (14 vs. 26%, P = 0.003). CONCLUSION: Hyperspectral computed tomographic spectroscopy is a clinically feasible method for measurement and analysis of vascular oxygen content in retinal health and disease. This study uses the techniques relevant to oximetry; however, the breadth of spectral data available through this method may be applicable to study other anatomical and functional features of the retina in health and disease.
PURPOSE: This pilot study was aimed to demonstrate the clinical feasibility of using hyperspectral computed tomographic spectroscopy to measure blood oxygen content in human retinal vessels. METHODS: All procedures were performed under a University of Southern California Institutional Review Board-approved protocol and after obtaining informed consent. Fifty-seven subjects with and without diabetic retinopathy were dilated for standard fundus photography. Fundus photographs and retinal vascular oxygen measurements (oximetry) were made using a custom-made hyperspectral computed tomographic imaging spectrometer coupled to a standard fundus camera. Oximetry measurements were made along arteries (Aox) and veins (Vox) within vessel segments that were 1 to 2 disk diameters from the optic disk. RESULTS: For all control subjects (n = 45), mean Aox and Vox were 93 ± 7% and 65 ± 5% (P = 0.001), respectively. For all diabetic subjects (n = 12), mean Aox and Vox were 90 ± 7% and 68 ± 5% (P = 0.001), respectively. In subjects with proliferative diabetic retinopathy, Aox was significantly lower, and Vox was significantly higher than other groups (85 ± 4% and 71 ± 4%, respectively; P = 0.04, analysis of variance). There was a highly significant difference in the arteriovenous difference between subjects with proliferative diabetic retinopathy and those in the control group (14 vs. 26%, P = 0.003). CONCLUSION: Hyperspectral computed tomographic spectroscopy is a clinically feasible method for measurement and analysis of vascular oxygen content in retinal health and disease. This study uses the techniques relevant to oximetry; however, the breadth of spectral data available through this method may be applicable to study other anatomical and functional features of the retina in health and disease.
Authors: Selin L Auvazian; Jennifer Cano; Sophie Leahy; Preny Karamian; Amir Kashani; Andrew Moshfeghi; Hossein Ameri; Norman P Blair; Mahnaz Shahidi Journal: Transl Vis Sci Technol Date: 2021-05-03 Impact factor: 3.283
Authors: Norman P Blair; Justin Wanek; Anthony E Felder; Charlotte E Joslin; Jacob K Kresovich; Jennifer I Lim; Felix Y Chau; Yannek Leiderman; Mahnaz Shahidi Journal: Invest Ophthalmol Vis Sci Date: 2017-10-01 Impact factor: 4.799
Authors: Sophie Lemmens; Jan Van Eijgen; Karel Van Keer; Julie Jacob; Sinéad Moylett; Lies De Groef; Toon Vancraenendonck; Patrick De Boever; Ingeborg Stalmans Journal: Transl Vis Sci Technol Date: 2020-08-05 Impact factor: 3.283
Authors: Tal Ben Ami; Yuehong Tong; Alauddin Bhuiyan; Carrie Huisingh; Zsolt Ablonczy; Thomas Ach; Christine A Curcio; R Theodore Smith Journal: Transl Vis Sci Technol Date: 2016-05-17 Impact factor: 3.283